Somatic cell mutagenesis is a powerful tool for characterizing receptor systems. We reported previously two complementation groups of mutant cell lines derived from CD14-transfected Chinese hamster ovary–K1 fibroblasts defective in responses to bacterial endotoxin. Both classes of mutants expressed a normal gene product for Toll-like receptor (TLR)4, and fully responded to stimulation by tumor necrosis factor (TNF)-α or interleukin (IL)-1β. We identified the lesion in one of the complementation groups in the gene for MD-2, a putative TLR4 coreceptor. The nonresponder phenotype of this mutant was reversed by transfection with MD-2. Cloning of MD-2 from the nonresponder cell line revealed a point mutation in a highly conserved region resulting in a C95Y amino acid exchange. Both forms of MD-2 colocalized with TLR4 on the cell surface after transfection, but only the wild-type cDNA reverted the lipopolysaccharide (LPS) nonresponder phenotype. Furthermore, soluble MD-2, but not soluble MD-2C95Y, functioned to enable LPS responses in cells that expressed TLR4. Thus, MD-2 is a required component of the LPS signaling complex and can function as a soluble receptor for cells that do not otherwise express it. We hypothesize that MD-2 conformationally affects the extracellular domain of TLR4, perhaps resulting in a change in affinity for LPS or functioning as a portion of the true ligand for TLR4.
Skip Nav Destination
Article navigation
2 July 2001
Article|
July 02 2001
Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line: A Point Mutation in a Conserved Region of Md-2 Abolishes Endotoxin-Induced Signaling
Andra B. Schromm,
Andra B. Schromm
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
bResearch Center Borstel, 23845 Borstel, Germany
Search for other works by this author on:
Egil Lien,
Egil Lien
cInstitute of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, 7489 Trondheim, Norway
Search for other works by this author on:
Philipp Henneke,
Philipp Henneke
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Search for other works by this author on:
Jesse C. Chow,
Jesse C. Chow
dEisai Research Institute, Andover, MA 01810
Search for other works by this author on:
Atsutoshi Yoshimura,
Atsutoshi Yoshimura
eNagasaki University School of Dentistry, Nagasaki 852-8588, Japan
Search for other works by this author on:
Holger Heine,
Holger Heine
bResearch Center Borstel, 23845 Borstel, Germany
Search for other works by this author on:
Eicke Latz,
Eicke Latz
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Search for other works by this author on:
Brian G. Monks,
Brian G. Monks
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Search for other works by this author on:
David A. Schwartz,
David A. Schwartz
fDuke University Medical Center, Durham, NC 27710
Search for other works by this author on:
Kensuke Miyake,
Kensuke Miyake
gSaga Medical School, Saga 849-8501, Japan
Search for other works by this author on:
Douglas T. Golenbock
Douglas T. Golenbock
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Search for other works by this author on:
Andra B. Schromm
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
bResearch Center Borstel, 23845 Borstel, Germany
Egil Lien
cInstitute of Cancer Research and Molecular Biology, Norwegian University of Science and Technology, 7489 Trondheim, Norway
Philipp Henneke
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Jesse C. Chow
dEisai Research Institute, Andover, MA 01810
Atsutoshi Yoshimura
eNagasaki University School of Dentistry, Nagasaki 852-8588, Japan
Holger Heine
bResearch Center Borstel, 23845 Borstel, Germany
Eicke Latz
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Brian G. Monks
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
David A. Schwartz
fDuke University Medical Center, Durham, NC 27710
Kensuke Miyake
gSaga Medical School, Saga 849-8501, Japan
Douglas T. Golenbock
aEvans Biomedical Research Center, Boston University School of Medicine, Boston, MA 02118
Abbreviations used in this paper: bp, basepair; CHO, Chinese hamster ovary–K1 fibroblast; FBS, fetal bovine serum; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; JNK, c-Jun NH2-terminal kinase; MAP, mitogen-activated protein; NF, nuclear factor; TLR, Toll-like receptor.
Received:
December 13 2000
Revision Requested:
May 17 2001
Accepted:
May 22 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 194 (1): 79–88.
Article history
Received:
December 13 2000
Revision Requested:
May 17 2001
Accepted:
May 22 2001
Citation
Andra B. Schromm, Egil Lien, Philipp Henneke, Jesse C. Chow, Atsutoshi Yoshimura, Holger Heine, Eicke Latz, Brian G. Monks, David A. Schwartz, Kensuke Miyake, Douglas T. Golenbock; Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line: A Point Mutation in a Conserved Region of Md-2 Abolishes Endotoxin-Induced Signaling. J Exp Med 2 July 2001; 194 (1): 79–88. doi: https://doi.org/10.1084/jem.194.1.79
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement